AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Physical therapist with patient

OIG reports blast prior authorization use in Medicare Advantage

| 5 Min Read
Graph showing upward trend

More utilization drives U.S. health spending to nearly $5.3 trillion

| 4 Min Read
W keys from a keyboard

3 keys to getting paid and thriving in private practice

| 6 Min Read
Patient with a hand to chest

What doctors want patients to know about heart failure

| 12 Min Read